#Biopharma M&A

Merck (MRK) buys Cidara for $9.2bn as biopharma M&A tops $93bn

Merck said it would buy Cidara for $9.2 billion in cash, extending a biopharma M&A wave that reached $92.98 billion in the first four months of 2026.